The inhalation should be gentle, not a forceful sniff
In trials that added it to injected insulin, basal insulin requirements fell roughly 60% to 80% while control improved. Low-blood-sugar risk therefore tracks the insulin or sulfonylurea used alongside tirzepatide more than the tirzepatide dose itself
Patient selection considerations include: Adults with BMI 30 kg/m or 27 kg/m with weight-related comorbidities [1] [7] Contraindications must be carefully reviewed, including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis, gallbladder disease, severe gastrointestinal disease, or renal impairment requires caution Not recommended during pregnancy or lactation Clinicians should counsel patients that while inflammatory marker improvements have been observed in research settings, Zepbound is prescribed for weight management, not inflammation treatment
Kirby, Carolyn, and staff are amazing
Patients should prioritize hydration and report persistent symptoms to their healthcare provider